Details
Stereochemistry | ACHIRAL |
Molecular Formula | C24H18BrClN4O3S |
Molecular Weight | 557.847 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)C1=CC=C(NC(=O)CSC2=NN=C(Br)N2C3=C4C=CC=CC4=C(C=C3)C5CC5)C(Cl)=C1
InChI
InChIKey=MPNGLQDRSJNLPL-UHFFFAOYSA-N
InChI=1S/C24H18BrClN4O3S/c25-23-28-29-24(34-12-21(31)27-19-9-7-14(22(32)33)11-18(19)26)30(23)20-10-8-15(13-5-6-13)16-3-1-2-4-17(16)20/h1-4,7-11,13H,5-6,12H2,(H,27,31)(H,32,33)
Molecular Formula | C24H18BrClN4O3S |
Molecular Weight | 557.847 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 18:19:58 GMT 2023
by
admin
on
Fri Dec 15 18:19:58 GMT 2023
|
Record UNII |
363Z97G83I
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
Discovery and development of non-nucleoside reverse-transcriptase inhibitors
Created by
admin on Fri Dec 15 18:19:58 GMT 2023 , Edited by admin on Fri Dec 15 18:19:58 GMT 2023
|
PRIMARY | |||
|
878670-61-2
Created by
admin on Fri Dec 15 18:19:58 GMT 2023 , Edited by admin on Fri Dec 15 18:19:58 GMT 2023
|
PRIMARY | |||
|
363Z97G83I
Created by
admin on Fri Dec 15 18:19:58 GMT 2023 , Edited by admin on Fri Dec 15 18:19:58 GMT 2023
|
PRIMARY | |||
|
16221816
Created by
admin on Fri Dec 15 18:19:58 GMT 2023 , Edited by admin on Fri Dec 15 18:19:58 GMT 2023
|
PRIMARY | |||
|
File:RDEA806.svg
Created by
admin on Fri Dec 15 18:19:58 GMT 2023 , Edited by admin on Fri Dec 15 18:19:58 GMT 2023
|
PRIMARY | Chemical structure of RDEA806, a triazole NNRTI. |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Originator: Valeant Pharmaceuticals International; Developer: Ardea Biosciences; Class: Antigout, Antiretroviral, Benzoic acid, Small molecule, Triazole; Mechanism of Action: Non-nucleoside reverse transcriptase inhibitor; Highest Development Phase: Discontinued for HIV infections; Most Recent Events: 30 May 2014 Discontinued - Phase-II for HIV infections in Europe, including Germany and the UK prior to May 2014 (PO), 20 Jun 2012 Ardea Biosciences has been acquired by AstraZeneca, 03 Feb 2011 RDEA 806 is still available for licensing as of 03 Feb 2011. http://www.ardeabio.com/
|